No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in Botswana.

导出 OA

翻译打印收藏纠错

第一作者： Sajini,Souda

第一单位： *Botswana-Harvard AIDS Institute Partnership for HIV Research and Education, Gaborone, Botswana; †Department of Pathology, School of Medicine, University of Botswana, Gaborone, Botswana; ‡Harvard University, Cambridge, MA; §Department of Medicine and Pediatrics, Massachusetts General Hospital, Boston, MA; ‖Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA; ¶Department of Medicine, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA; and #Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA.

作者： Sajini,Souda ^[1] ; Simani,Gaseitsiwe ; Nathan,Georgette ; Kathleen,Powis ; Daisy,Moremedi ; Thato,Iketleng ; Jean,Leidner ; Claire,Moffat ; Anthony,Ogwu ; Shahin,Lockman ; Sikhulile,Moyo ; Mompati,Mmalane ; Rosemary,Musonda ; Joseph,Makhema ; Max,Essex ; Roger,Shapiro

作者单位： *Botswana-Harvard AIDS Institute Partnership for HIV Research and Education, Gaborone, Botswana; †Department of Pathology, School of Medicine, University of Botswana, Gaborone, Botswana; ‡Harvard University, Cambridge, MA; §Department of Medicine and Pediatrics, Massachusetts General Hospital, Boston, MA; ‖Department of Immunology and Infectious Diseases, Harvard School of Public Health, Boston, MA; ¶Department of Medicine, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA; and #Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA. ^[1]